Regeneus Ltd (ASX:RGS) Featured in Morgans' 'Under The Microscope' Podcast series
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, was recently featured in the 'Under the Microscope' podcast series from Morgans.
Regeneus CEO Leo Lee spoke with Ian Wilkie, an Analyst at Morgans, about the company's platform technologies Progenza and Sygenus, why there is an unmet need in pain and inflammation treatment and how the company's novel stem cell technology address this market.
In the interview, Leo also highlighted the company's upcoming milestones and why he believes stem cell technologies have the potential to be the next plaform to address major diseases and chronic illnesses.
To listen to the full interview, please visit:
https://www.abnnewswire.net/lnk/RE78GTV7
Investors Sandra McIntosh Company Secretary and Investor Relations Regeneus Ltd T: +61-2-9499-8010 E: investors@regeneus.com.au Media Daniel Paperny Media and Capital Partners T: +61-405-191-257 E: Daniel.paperny@mcpartners.com.au
News Provided by ABN Newswire